Alert icon

To align with industry best practices for security and data integrity, Project Data Sphere is requiring users to upgrade their browsers to one that supports encryption protocol TLS 1.2 by December 15, 2017. On that date, Project Data Sphere will disable support of browsers that permit SSL 3.0/TLS 1.0. To prevent any disruption to your access to Project Data Sphere, you must take action.
This browser was not recognized and may not be compatible with TLS 1.2 or higher. Please check with the browser's developer to confirm.
To view information about this, please visit the FAQ. If you have any further questions, please contact us.

Back to the List
Type(s) of Cancer
Prostate
Study Phase
Phase 3
Study Completion Date
July 2010
NCT00286091Uploaded 09-26-2016
Available for Download
PDS UID: Prostat_Amgen_2006_155
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Phase 3 Study of Denosumab on Prolonging Bone Metastasis-Free Survival in Men With Hormone Refractory Prostate Cancer
Files:
PROTOCOL20050147 Protocol Amend 4 REDACTED.pdf
CRFAmgen 20050147 CRF REDACTED.pdf
DATA DICTIONARYAmgen 20050147 DDT.pdf
DATA (COMPARATOR ARM)Amgen 20050147 SAS datasets.zip